Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,470 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer.
Takeda S, Shigeyasu K, Okugawa Y, Yoshida K, Mori Y, Yano S, Noma K, Umeda Y, Kondo Y, Kishimoto H, Teraishi F, Nagasaka T, Tazawa H, Kagawa S, Fujiwara T, Goel A. Takeda S, et al. Among authors: yano s. Cancer Lett. 2019 Mar 1;444:127-135. doi: 10.1016/j.canlet.2018.12.009. Epub 2018 Dec 21. Cancer Lett. 2019. PMID: 30583079 Free PMC article.
Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma.
Konishi D, Umeda Y, Yoshida K, Shigeyasu K, Yano S, Toji T, Takeda S, Yoshida R, Yasui K, Fuji T, Matsumoto K, Kishimoto H, Michiue H, Teraishi F, Kato H, Tazawa H, Yanai H, Yagi T, Goel A, Fujiwara T. Konishi D, et al. Among authors: yano s. Br J Cancer. 2022 Sep;127(4):757-765. doi: 10.1038/s41416-022-01838-y. Epub 2022 May 21. Br J Cancer. 2022. PMID: 35597869 Free PMC article.
RNA editing facilitates the enhanced production of neoantigens during the simultaneous administration of oxaliplatin and radiotherapy in colorectal cancer.
Komatsu Y, Shigeyasu K, Yano S, Takeda S, Takahashi K, Hata N, Umeda H, Yoshida K, Mori Y, Yasui K, Yoshida R, Kondo Y, Kishimoto H, Teraishi F, Umeda Y, Kagawa S, Michiue H, Tazawa H, Goel A, Fujiwara T. Komatsu Y, et al. Among authors: yano s. Sci Rep. 2022 Aug 8;12(1):13540. doi: 10.1038/s41598-022-17773-0. Sci Rep. 2022. PMID: 35941214 Free PMC article.
ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer.
Hata N, Shigeyasu K, Umeda Y, Yano S, Takeda S, Yoshida K, Fuji T, Yoshida R, Yasui K, Umeda H, Takahashi T, Kondo Y, Kishimoto H, Mori Y, Teraishi F, Yamamoto H, Michiue H, Nakamura K, Tazawa H, Fujiwara T. Hata N, et al. Among authors: yano s. Sci Rep. 2023 Feb 6;13(1):2078. doi: 10.1038/s41598-023-29397-z. Sci Rep. 2023. PMID: 36747029 Free PMC article.
RNA Editing is a Valuable Biomarker for Predicting Carcinogenesis in Ulcerative Colitis.
Takahashi K, Shigeyasu K, Kondo Y, Gotoh K, Yano S, Umeda Y, Inokuchi T, Xu C, Yoshida K, Umeda H, Takahashi T, Takeda S, Yoshida R, Teraishi F, Kishimoto H, Mori Y, Noma K, Okugawa Y, Hiraoka S, Michiue H, Tazawa H, Matsushita O, Goel A, Fujiwara T. Takahashi K, et al. Among authors: yano s. J Crohns Colitis. 2023 May 3;17(5):754-766. doi: 10.1093/ecco-jcc/jjac186. J Crohns Colitis. 2023. PMID: 36528792 Free article.
2,470 results